Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    April 2017
  1. RAGONESE P
    Mortality studies for multiple sclerosis: still a useful tool to analyse long-term outcome.
    J Neurol Neurosurg Psychiatry. 2017 Apr 28. pii: jnnp-2017-315591.
    PubMed     Text format    


  2. OKADA K, Kobata M, Sennari Y, Iwanaka Y, et al
    Levels of nitric oxide metabolites in cerebrospinal fluid correlate with cognitive impairment in early stage multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Apr 26. pii: jnnp-2017-315585.
    PubMed     Text format    


  3. LUNDE HB, Assmus J, Kjell-Morten M, Bo L, et al
    Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
    J Neurol Neurosurg Psychiatry. 2017 Apr 1. pii: jnnp-2016-315238.
    PubMed     Text format     Abstract available


  4. COMI G, De Stefano N, Freedman MS, Barkhof F, et al
    Subcutaneous interferon beta-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study.
    J Neurol Neurosurg Psychiatry. 2017;88:285-294.
    PubMed     Text format     Abstract available


    March 2017
  5. MURPHY R, O'Donoghue S, Counihan T, McDonald C, et al
    Neuropsychiatric syndromes of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 11. pii: jnnp-2016-315367.
    PubMed     Text format     Abstract available


    December 2016
  6. ROCCA MA, Filippi M
    Modulation of cortical excitability to normalise brain function and improve cognition in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Dec 30. pii: jnnp-2016-315195.
    PubMed     Text format    


  7. HULST HE, Goldschmidt T, Nitsche MA, de Wit SJ, et al
    rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Dec 14. pii: jnnp-2016-314224.
    PubMed     Text format     Abstract available


    November 2016
  8. TAO C, Simpson S Jr, van der Mei I, Blizzard L, et al
    Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Nov 3. pii: jnnp-2016-314013.
    PubMed     Text format     Abstract available


    October 2016
  9. MOROSO A, Ruet A, Lamargue-Hamel D, Munsch F, et al
    Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Oct 27. pii: jnnp-2016-313867.
    PubMed     Text format     Abstract available


    September 2016
  10. LIZAK N, Lugaresi A, Alroughani R, Lechner-Scott J, et al
    Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Sep 28. pii: jnnp-2016-313976.
    PubMed     Text format     Abstract available


  11. KAWACHI I, Lassmann H
    Neurodegeneration in multiple sclerosis and neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313300.
    PubMed     Text format     Abstract available


  12. PARDINI M, Sudre CH, Prados F, Yaldizli O, et al
    Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Sep 6. pii: jnnp-2016-313979.
    PubMed     Text format     Abstract available


    August 2016
  13. PAN G, Simpson S Jr, van der Mei I, Charlesworth JC, et al
    Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    J Neurol Neurosurg Psychiatry. 2016 Aug 24. pii: jnnp-2016-313722.
    PubMed     Text format     Abstract available


    June 2016
  14. FAREZ MF
    Salt intake in multiple sclerosis: friend or foe?
    J Neurol Neurosurg Psychiatry. 2016 Jun 27. pii: jnnp-2016-313768.
    PubMed     Text format    


  15. NOURBAKHSH B, Graves J, Casper TC, Lulu S, et al
    Dietary salt intake and time to relapse in paediatric multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Jun 24. pii: jnnp-2016-313410.
    PubMed     Text format     Abstract available


  16. SIMPSON A, Pereira M, Cooper S, Ramagopalan SV, et al
    Seasonality of tweets related to multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Jun 8. pii: jnnp-2016-313941.
    PubMed     Text format    


    May 2016
  17. PATTI F, Messina S, Solaro C, Amato MP, et al
    Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
    J Neurol Neurosurg Psychiatry. 2016 May 9. pii: jnnp-2015-312591.
    PubMed     Text format     Abstract available


    April 2016
  18. MOCCIA M, Palladino R, Falco A, Sacca F, et al
    Google Trends: new evidence for seasonality of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Apr 15. pii: jnnp-2016-313260.
    PubMed     Text format    


  19. WANG C, Beadnall HN, Hatton SN, Bader G, et al
    Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
    J Neurol Neurosurg Psychiatry. 2016 Apr 12. pii: jnnp-2015-312304.
    PubMed     Text format     Abstract available


    March 2016
  20. WIJNANDS JM, Kingwell E
    Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Mar 3. pii: jnnp-2015-312431.
    PubMed     Text format    


  21. HEDSTROM AK, Mowry EM, Gianfrancesco MA, Shao X, et al
    High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
    J Neurol Neurosurg Psychiatry. 2016 Mar 3. pii: jnnp-2015-312176.
    PubMed     Text format     Abstract available


    February 2016
  22. ZHOVTIS RYERSON L, Frohman TC, Foley J, Kister I, et al
    Extended interval dosing of natalizumab in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Feb 25. pii: jnnp-2015-312940.
    PubMed     Text format     Abstract available


  23. MCGUIGAN C, Craner M, Guadagno J, Kapoor R, et al
    Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
    J Neurol Neurosurg Psychiatry. 2016;87:117-25.
    PubMed     Text format     Abstract available


  24. DISANTO G, Adiutori R, Dobson R, Martinelli V, et al
    Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
    J Neurol Neurosurg Psychiatry. 2016;87:126-9.
    PubMed     Text format     Abstract available


  25. HOEPNER R, Klotz P, Faissner S, Schneider R, et al
    Neuropsychological impairment in natalizumab-associated progressive multifocal leukoencephalopathy: implications for early diagnosis.
    J Neurol Neurosurg Psychiatry. 2016;87:224-6.
    PubMed     Text format    


    December 2015
  26. DOGONOWSKI AM, Blinkenberg M, Paulson OB, Sellebjerg F, et al
    Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Dec 14. pii: jnnp-2015-311375.
    PubMed     Text format    


    October 2015
  27. MASUDA S, Mori M, Arai K, Uzawa A, et al
    Epstein-Barr virus persistence and reactivation in neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2015;86:1137-42.
    PubMed     Text format     Abstract available


    September 2015
  28. HEIDENREICH F
    Long-term treatment of relapsing-remitting multiple sclerosis with interferon beta: how strongly should we encourage patients to adhere to the 'old' therapies?
    J Neurol Neurosurg Psychiatry. 2015 Sep 16. pii: jnnp-2015-310763.
    PubMed     Text format    


  29. KAPPOS L, Kuhle J, Multanen J, Kremenchutzky M, et al
    Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
    J Neurol Neurosurg Psychiatry. 2015 Sep 15. pii: jnnp-2014-310024.
    PubMed     Text format     Abstract available


    August 2015
  30. SETHI V, Yousry T, Muhlert N, Tozer DJ, et al
    A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Aug 13. pii: jnnp-2015-311102.
    PubMed     Text format     Abstract available


  31. MORI M
    Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
    J Neurol Neurosurg Psychiatry. 2015;86:823.
    PubMed     Text format    


    July 2015
  32. WATTJES MP, Vennegoor A, Steenwijk MD, de Vos M, et al
    MRI pattern in asymptomatic natalizumab-associated PML.
    J Neurol Neurosurg Psychiatry. 2015;86:793-8.
    PubMed     Text format     Abstract available


    June 2015
  33. COHEN JA, Khatri B, Barkhof F, Comi G, et al
    Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
    J Neurol Neurosurg Psychiatry. 2015 Jun 25. pii: jnnp-2015-310597.
    PubMed     Text format     Abstract available


  34. KOCH MW, Greenfield J, Javizian O, Deighton S, et al
    The natural history of early versus late disability accumulation in primary progressive MS.
    J Neurol Neurosurg Psychiatry. 2015;86:615-21.
    PubMed     Text format     Abstract available


    April 2015
  35. ABSOUD M, Lim MJ, Appleton R, Jacob A, et al
    Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
    J Neurol Neurosurg Psychiatry. 2015;86:470-2.
    PubMed     Text format     Abstract available


    March 2015
  36. BAUMANN M, Sahin K, Lechner C, Hennes EM, et al
    Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    J Neurol Neurosurg Psychiatry. 2015;86:265-72.
    PubMed     Text format     Abstract available


  37. LALIVE PH, Bridel C, Ferfoglia RI, Kaiser L, et al
    Minimal supportive treatment in natalizumab-related PML in a MS patient.
    J Neurol Neurosurg Psychiatry. 2015;86:354-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: